AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies

Executives Discuss AION Labs, a First-of-its-Kind Innovation Lab Focused on AI Technologies

AI providing the edge against cancer?

AION Labs Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates

AION Labs Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates

Driving innovation in pharma AI

An Israeli Lab Tests A Unique Way Of Collaborating and Scaling AI

AION Labs spots ‘unique opportunity’ for AI-driven antibody discovery

Newly-Launched AION Forms Startup in Israel

A partnership between six leading tech and pharma companies wants to create and adopt new AI technologies that could transform the process of drug discovery and development.